Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marius M Hoeper

Showing results (261-270 of 311) with videos related to

Pageof 32
Sort By:
Cellular & Molecular Immunology|November 3, 2020
Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19 convalescent patients revealed by two different detection methodsBerislav Bošnjak, Saskia Catherina Stein, Stefanie Willenzon, et al.
The American Journal of Pathology|June 1, 2022
A Morphomolecular Approach to Alveolar Capillary DysplasiaJan C Kamp, Lavinia Neubert, Maximilian Ackermann, et al.
The New England Journal of Medicine|August 27, 2015
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial HypertensionNazzareno Galiè, Joan A Barberà, Adaani E Frost, et al.
The New England Journal of Medicine|August 2, 2002
Inhaled iloprost for severe pulmonary hypertensionHorst Olschewski, Gerald Simonneau, Nazzareno Galiè, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 16, 2021
Humoral and Cellular Immune Responses Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants and Human Coronaviruses After Single BNT162b2 VaccinationMetodi V Stankov, Anne Cossmann, Agnes Bonifacius, et al.
Deutsche Medizinische Wochenschrift (1946)|July 6, 2019
[Hemodynamic Definition of Pulmonary Hypertension: Commentary on the Proposed Change by the 6th World Symposium on Pulmonary Hypertension]Stephan Rosenkranz, Gerhard-Paul Diller, Daniel Dumitrescu, et al.
Journal of the American College of Cardiology|February 16, 2018
Pulmonary Arterial Hypertension-Related Morbidity Is Prognostic for MortalityVallerie V McLaughlin, Marius M Hoeper, Richard N Channick, et al.
The New England Journal of Medicine|March 6, 2023
Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial HypertensionMarius M Hoeper, David B Badesch, H Ardeschir Ghofrani, et al.
The American Journal of Pathology|November 29, 2023
Multilamellated Basement Membranes in the Capillary Network of Alveolar Capillary DysplasiaJan C Kamp, Lavinia Neubert, Jonas C Schupp, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 7, 2024
Efficacy and safety of sotatercept across ranges of cardiac index in patients with pulmonary arterial hypertension: A pooled analysis of PULSAR and STELLARMardi Gomberg-Maitland, David B Badesch, J Simon R Gibbs, et al.
Pageof 32

Showing results (261-270 of 311) with videos related to

Sort By:
Pageof 32
Cellular & Molecular Immunology|November 3, 2020
Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19 convalescent patients revealed by two different detection methodsBerislav Bošnjak, Saskia Catherina Stein, Stefanie Willenzon, et al.
The American Journal of Pathology|June 1, 2022
A Morphomolecular Approach to Alveolar Capillary DysplasiaJan C Kamp, Lavinia Neubert, Maximilian Ackermann, et al.
The New England Journal of Medicine|August 27, 2015
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial HypertensionNazzareno Galiè, Joan A Barberà, Adaani E Frost, et al.
The New England Journal of Medicine|August 2, 2002
Inhaled iloprost for severe pulmonary hypertensionHorst Olschewski, Gerald Simonneau, Nazzareno Galiè, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 16, 2021
Humoral and Cellular Immune Responses Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants and Human Coronaviruses After Single BNT162b2 VaccinationMetodi V Stankov, Anne Cossmann, Agnes Bonifacius, et al.
Deutsche Medizinische Wochenschrift (1946)|July 6, 2019
[Hemodynamic Definition of Pulmonary Hypertension: Commentary on the Proposed Change by the 6th World Symposium on Pulmonary Hypertension]Stephan Rosenkranz, Gerhard-Paul Diller, Daniel Dumitrescu, et al.
Journal of the American College of Cardiology|February 16, 2018
Pulmonary Arterial Hypertension-Related Morbidity Is Prognostic for MortalityVallerie V McLaughlin, Marius M Hoeper, Richard N Channick, et al.
The New England Journal of Medicine|March 6, 2023
Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial HypertensionMarius M Hoeper, David B Badesch, H Ardeschir Ghofrani, et al.
The American Journal of Pathology|November 29, 2023
Multilamellated Basement Membranes in the Capillary Network of Alveolar Capillary DysplasiaJan C Kamp, Lavinia Neubert, Jonas C Schupp, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 7, 2024
Efficacy and safety of sotatercept across ranges of cardiac index in patients with pulmonary arterial hypertension: A pooled analysis of PULSAR and STELLARMardi Gomberg-Maitland, David B Badesch, J Simon R Gibbs, et al.
Pageof 32